TALE factors use two distinct functional modes to control an essential zebrafish gene expression program
Abstract
TALE factors are broadly expressed embryonically and known to function in complexes with transcription factors (TFs) like Hox proteins at gastrula/segmentation stages, but it is unclear if such generally expressed factors act by the same mechanism throughout embryogenesis. We identify a TALE-dependent gene regulatory network (GRN) required for anterior development and detect TALE occupancy associated with this GRN throughout embryogenesis. At blastula stages, we uncover a novel functional mode for TALE factors, where they occupy genomic DECA motifs with nearby NF-Y sites. We demonstrate that TALE and NF-Y form complexes and regulate chromatin state at genes of this GRN. At segmentation stages, GRN-associated TALE occupancy expands to include HEXA motifs near PBX:HOX sites. Hence, TALE factors control a key GRN, but utilize distinct DNA motifs and protein partners at different stages - a strategy that may also explain their oncogenic potential and may be employed by other broadly expressed TFs.
Data availability
RNA-seq data has been deposited in GEO under accession code GSE102662ChIP-seq data has been deposited in ArrayExpress under accession code E-MTAB-5967
-
Zebrafish TALE KD RNA-seqPublicly available at the NCBI Gene Expression Omnibus (accession no: GSE102662).
-
Prep1 (ChIP-Seq)Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1545025).
-
H3K4me1_dome, danRer7Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM915193).
-
H3K4me3_dome, danRer7Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM915189).
-
H3K27ac_dome, danRer7Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM915197.
-
H3K27ac_80%epi, danRer7Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM915198).
-
H3K27ac_24hpf, danRer7Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM915199).
-
H3K27me3 ChIP-seq domePublicly available at the NCBI Gene Expression Omnibus (accession no: GSM1081557).
-
nucleosome dome rep 1Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1081554).
-
Pol II ChIP-seq dome 8WG16Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1081560).
-
MeDIP_4.5hpfPublicly available at the NCBI Gene Expression Omnibus (accession no: GSM1274386).
-
ChIP-Seq NF-YAPublicly available at the NCBI Gene Expression Omnibus (accession no: GSM1370111).
-
LICR_ChipSeq_ES-E14_H3K4me1_E0Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1000121).
-
LICR_ChipSeq_ES-E14_H3K4me3_E0Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1000124).
-
LICR_ChipSeq_ES-E14_H3K27ac_E0Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1000126).
-
LICR_ChipSeq_ES-Bruce4_H3K27me3_EPublicly available at the NCBI Gene Expression Omnibus (accession no: GSM1000089).
-
UW_DnaseSeq_ES-E14_E0_129/OlaPublicly available at the NCBI Gene Expression Omnibus (accession no: GSM1014154).
-
E14 MeDIP-seqPublicly available at the NCBI Gene Expression Omnibus (accession no: GSM859494).
-
Input_DNA (ChIP-Seq control)Publicly available at the NCBI Gene Expression Omnibus (accession no: GSM1545026).
Article and author information
Author details
Funding
National Institute of Neurological Disorders and Stroke (NS38183)
- Charles G Sagerström
Biotechnology and Biological Sciences Research Council (BB/N00907X/1)
- Nicoletta Bobola
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Marianne Bronner, California Institute of Technology, United States
Ethics
Animal experimentation: This study was submitted to and approved by the University of Massachusetts Medical School Institutional Animal Care and Use Committee (protocol A-1565) and the University of Massachusetts Medical School Institutional Review Board (protocol I-149).
Version history
- Received: February 22, 2018
- Accepted: June 8, 2018
- Accepted Manuscript published: June 18, 2018 (version 1)
- Version of Record published: June 28, 2018 (version 2)
Copyright
© 2018, Ladam et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,487
- views
-
- 167
- downloads
-
- 20
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Developmental Biology
- Structural Biology and Molecular Biophysics
The receptor tyrosine kinase ROR2 mediates noncanonical WNT5A signaling to orchestrate tissue morphogenetic processes, and dysfunction of the pathway causes Robinow syndrome, brachydactyly B, and metastatic diseases. The domain(s) and mechanisms required for ROR2 function, however, remain unclear. We solved the crystal structure of the extracellular cysteine-rich (CRD) and Kringle (Kr) domains of ROR2 and found that, unlike other CRDs, the ROR2 CRD lacks the signature hydrophobic pocket that binds lipids/lipid-modified proteins, such as WNTs, suggesting a novel mechanism of ligand reception. Functionally, we showed that the ROR2 CRD, but not other domains, is required and minimally sufficient to promote WNT5A signaling, and Robinow mutations in the CRD and the adjacent Kr impair ROR2 secretion and function. Moreover, using function-activating and -perturbing antibodies against the Frizzled (FZ) family of WNT receptors, we demonstrate the involvement of FZ in WNT5A-ROR signaling. Thus, ROR2 acts via its CRD to potentiate the function of a receptor super-complex that includes FZ to transduce WNT5A signals.
-
- Cell Biology
- Developmental Biology
The generation of distinct cell fates during development depends on asymmetric cell division of progenitor cells. In the central and peripheral nervous system of Drosophila, progenitor cells respectively called neuroblasts or sensory organ precursors use PAR polarity during mitosis to control cell fate determination in their daughter cells. How polarity and the cell cycle are coupled, and how the cell cycle machinery regulates PAR protein function and cell fate determination is poorly understood. Here, we generate an analog sensitive allele of CDK1 and reveal that its partial inhibition weakens but does not abolish apical polarity in embryonic and larval neuroblasts and leads to defects in polarisation of fate determinants. We describe a novel in vivo phosphorylation of Bazooka, the Drosophila homolog of PAR-3, on Serine180, a consensus CDK phosphorylation site. In some tissular contexts, phosphorylation of Serine180 occurs in asymmetrically dividing cells but not in their symmetrically dividing neighbours. In neuroblasts, Serine180 phosphomutants disrupt the timing of basal polarisation. Serine180 phosphomutants also affect the specification and binary cell fate determination of sensory organ precursors as well as Baz localisation during their asymmetric cell divisions. Finally, we show that CDK1 phosphorylates Serine-S180 and an equivalent Serine on human PAR-3 in vitro.